Global investment firm Carlyleβs bet on two healthcare revenue cycle management (RCM) providers, Knack RCM and EqualizeRCM, in India is more than just an acquisition story. The private equity firm plans to raise $400 million by listing the combined entity by early 2027, according to Bloomberg.
Carlyle is running its core playbook by replicating strategies that worked for it across automotive components and pharmaceuticals. Its history of acquiring healthcare platforms such as Indegene, Visionary RCM, and CorroHealth adds to this pattern, and the latest deal solidifies its platform strategy.
Since both Knack RCM and EqualizeRCM run a large part of their operations from India, employing around 8,000 people globally, the country has again proven to be a differentiator, this time in healthcare RCM. But many see this development as a new opening for nearshore operators as well.
The questions that need some exploration are: are nearshore players ready to take cues from the deal and move fast to score similar deals in healthcare RCM by positioning themselves as a better alternative? We asked nearshore experts about strategies that can help them win these deals.